Originally described in melanoma, the mutations in human TERT promoter, mainly at -124 and -146 base pair positions from the ATG start site, have been shown to be common in certain tumor types including BC of all stages with mutation frequencies of up to 80% [16–20]. Here, TERT is linked to neoplasm.